Cargando…

Human T cells recognize HLA-DP–bound peptides in two orientations

Human leukocyte antigen (HLA) molecules present small peptide antigens to T cells, thereby allowing them to recognize pathogen-infected and cancer cells. A central dogma over the last 50+ y is that peptide binding to HLA molecules is mediated by the docking of side chains of particular amino acids i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klobuch, Sebastian, Lim, Jia Jia, van Balen, Peter, Kester, Michel G. D., de Klerk, Wendy, de Ru, Arnoud H., Pothast, Cilia R., Jedema, Inge, Drijfhout, Jan W., Rossjohn, Jamie, Reid, Hugh H., van Veelen, Peter A., Falkenburg, J. H. Frederik, Heemskerk, Mirjam H. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894132/ https://www.ncbi.nlm.nih.gov/pubmed/36442096 http://dx.doi.org/10.1073/pnas.2214331119

Ejemplares similares

Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity
por: Laghmouchi, Aicha, et al.
Publicado: (2022)

The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells
por: Laghmouchi, Aicha, et al.
Publicado: (2019)

SARS-CoV-2-specific CD4(+) and CD8(+) T cell responses can originate from cross-reactive CMV-specific T cells
por: Pothast, Cilia R, et al.
Publicado: (2022)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
por: van Balen, Peter, et al.
Publicado: (2018)

Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing
por: Arrieta-Bolaños, Esteban, et al.
Publicado: (2018)

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
por: van Balen, Peter, et al.
Publicado: (2020)

S78. Proffered paper: High-affinity CD20-specific TCRs suitable for adoptive immunotherapy can be readily isolated from the allo-repertoire using reverse immunology
por: Jahn, L, et al.
Publicado: (2014)

A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer
por: Jahn, Lorenz, et al.
Publicado: (2016)

Generation of CD20-specific TCRs for TCR gene therapy of CD20(low) B-cell malignancies insusceptible to CD20-targeting antibodies
por: Jahn, Lorenz, et al.
Publicado: (2016)

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II
por: van Balen, Peter, et al.
Publicado: (2018)

WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma
por: van Amerongen, Rosa A, et al.
Publicado: (2022)

Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells
por: Laghmouchi, Aicha, et al.
Publicado: (2020)

Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors( )
por: Huisman, Wesley, et al.
Publicado: (2020)

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain
por: Meeuwsen, Miranda H., et al.
Publicado: (2023)

Reprogramming of Virus-specific T Cells into Leukemia-reactive T Cells Using T Cell Receptor Gene Transfer
por: Heemskerk, Mirjam H.M., et al.
Publicado: (2004)

HSPVdb—the Human Short Peptide Variation Database for improved mass spectrometry-based detection of polymorphic HLA-ligands
por: Nijveen, Harm, et al.
Publicado: (2010)

A library of cancer testis specific T cell receptors for T cell receptor gene therapy
por: de Rooij, Marije A.J., et al.
Publicado: (2022)

A library of cancer testis specific T cell receptors for T cell receptor gene therapy
por: de Rooij, Marije A.J., et al.
Publicado: (2023)

P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
por: van Loenen, MM, et al.
Publicado: (2014)

Magnitude of Off-Target Allo-HLA Reactivity by Third-Party Donor-Derived Virus-Specific T Cells Is Dictated by HLA-Restriction
por: Huisman, Wesley, et al.
Publicado: (2021)

High-Throughput Identification of Potential Minor Histocompatibility Antigens by MHC Tetramer-Based Screening: Feasibility and Limitations
por: Hombrink, Pleun, et al.
Publicado: (2011)

Extracellular Domains of CD8α and CD8ß Subunits Are Sufficient for HLA Class I Restricted Helper Functions of TCR-Engineered CD4(+) T Cells
por: van Loenen, Marleen M., et al.
Publicado: (2013)

Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule
por: Wiesner, Martina, et al.
Publicado: (2008)

Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity?
por: Hanssen, Jaap L. J., et al.
Publicado: (2021)

Structure of the DP1–DP2 PolD complex bound with DNA and its implications for the evolutionary history of DNA and RNA polymerases
por: Raia, Pierre, et al.
Publicado: (2019)

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
por: van der Lee, Dyantha I., et al.
Publicado: (2021)

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
por: van Amerongen, Rosa A., et al.
Publicado: (2023)

The nonpolymorphic MHC Qa-1(b) mediates CD8(+) T cell surveillance of antigen-processing defects
por: Oliveira, Cláudia C., et al.
Publicado: (2010)

The nonpolymorphic MHC Qa-1(b) mediates CD8(+) T cell surveillance of antigen-processing defects
por: Oliveira, Cláudia C., et al.
Publicado: (2010)

Amino acids at position 5 in the peptide/MHC binding region of a public virus‐specific TCR are completely inter‐changeable without loss of function
por: Huisman, Wesley, et al.
Publicado: (2022)

Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing
por: Huisman, W., et al.
Publicado: (2022)

In-Depth Specificity Profiling of Endopeptidases Using Dedicated Mix-and-Split Synthetic Peptide Libraries and Mass Spectrometry
por: Claushuis, Bart, et al.
Publicado: (2023)

A Note on D(p-2),Dp Bound State and Noncommutative Yang-Mills Theory
por: Youm, Donam
Publicado: (2000)

P1570: SARS-COV-2 HUMORAL AND CELLULAR VACCINATION RESPONSE IN PATIENTS WITH LYMPHOID HAEMATOLOGICAL MALIGNANCIES
por: Boerenkamp, L. S., et al.
Publicado: (2022)

Clinically applicable CD34(+)-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses
por: van Eck van der Sluijs, Jesper, et al.
Publicado: (2021)

Healthy cells functionally present TAP-independent SSR1 peptides: implications for selection of clinically relevant antigens
por: de Waard, Antonius A., et al.
Publicado: (2021)

Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
por: Vader, L. Willemijn, et al.
Publicado: (2002)

Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells
por: van Luijn, Marvin M., et al.
Publicado: (2012)

Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals
por: Huisman, Wesley, et al.
Publicado: (2022)

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion
por: Morton, Laura T, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aafj46jcpe1mmhseuafn7h8aia